Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
TransThera Announces that the IND Application of TT-01488, a Non-covalent Reversible BTK Inhibitor, for the Treatment of B-Cell Lymphomas has been Approved by the FDA in the US and Officially Accepted by the NMPA in China
2022-02-18 22:00
PolyActiva Announces Positive Phase IIa Trial Results in Low Dose Cohort for PA5108 Ocular Implant with Prezia™ Sustained Drug Delivery Technology
2022-02-18 08:19
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin's Lymphoma
2022-02-17 21:30
Flat Medical joins the Stay Connected(R), the International Organization for Safer Neuraxial Anesthesia
2022-02-17 21:00
Seegene Announces Q4 and Full-Year 2021 Financial Results
2022-02-17 20:00
Small Molecule Targeting CD47-SIRPα Pathway: Insilico Medicine Achieves its First Major Milestone in Fosun Pharma Collaboration with the Nomination of Preclinical Candidate for QPCTL
2022-02-17 16:30
Kato Wins FDA Approval for Human Studies of Drug for Retinal Disorders
2022-02-17 12:14
CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) and RET-Altered Thyroid Cancers in Taiwan, China
2022-02-17 09:19
Cambridge Nutranostics has developed a point-of-care OCCL test prototype for testing blood plasma oxygen to monitor pregnancy health
2022-02-17 09:00
Innovent Announces Two Registration Studies of IBI306 (anti-PCSK-9 antibody) Met Primary Endpoint
2022-02-17 08:00
BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding activity of hapten-modified SARS-CoV-2 protein
2022-02-16 21:00
LIMACORPORATE'S ADVANCED TESTING FACILITY RECEIVES ISO 17025 CERTIFICATION BY ACCREDIA
2022-02-16 21:00
Meihua International Medical Technologies Co., Ltd. Announces Pricing of $36,000,000 Initial Public Offering
2022-02-16 20:34
PharmaBlock Appoints Dr. Zhengtian Gu as Senior Vice President of Quality and Regulatory Affairs
2022-02-16 20:00
JIXING ANNOUNCES RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR AFICAMTEN IN CHINA
2022-02-16 18:06
Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC)
2022-02-16 17:04
Nippon Express (China) Donates Protective Suits to China Railway Express Terminal Station in Xi'an
2022-02-16 15:00
NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody
2022-02-16 14:00
A Breakthrough in Probiotic Therapy - Personalized Probiotics (Dispensing) Machine for a Balanced and Enhanced Immune System
2022-02-16 10:00
Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer
2022-02-15 22:35
1
286
287
288
289
290
896